|
1
|
Dai C, Kang J, Liu X, Yao Y, Wang H and
Wang R: How to classify and define pituitary tumors: Recent
advances and current controversies. Front Endocrinol (Lausanne).
12:6046442021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kong F, Cheng W and Zhan Q: Clinical study
on the selection of endoscopes and microscopes for transsphenoidal
surgery of non-aggressive pituitary macroadenoma and microadenoma
and the influencing factors of hyposmia after endoscopic
transsphenoidal surgery. Front Neurol. 15:13210992024. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Raverot G, Ilie MD, Lasolle H, Amodru V,
Trouillas J, Castinetti F and Brue T: Aggressive pituitary tumours
and pituitary carcinomas. Nat Rev Endocrinol. 17:671–684. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Burman P, Casar-Borota O, Perez-Rivas LG
and Dekkers OM: Aggressive pituitary tumors and pituitary
carcinomas: From pathology to treatment. J Clin Endocrinol Metab.
108:1585–1601. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Raverot G and Ilie MD: Immunotherapy in
pituitary carcinomas and aggressive pituitary tumors. Best Pract
Res Clin Endocrinol Metab. 36:1017122022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang Y, Chen B, Liang D, Quan X, Gu R,
Meng Z, Gan H, Wu Z, Sun Y, Liu S and Dou G: Pharmacological
effects of astragaloside IV: A review. Molecules. 28:61182023.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xia D, Li W, Tang C and Jiang J:
Astragaloside IV, as a potential anticancer agent. Front Pharmacol.
14:10655052023. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li L, Li G, Chen M and Cai R:
Astragaloside IV enhances the sensibility of lung adenocarcinoma
cells to bevacizumab by inhibiting autophagy. Drug Dev Res.
83:461–469. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu Y and Lu F: Astragaloside IV inhibits
cell viability and glycolysis of hepatocellular carcinoma by
regulating KAT2A-mediated succinylation of PGAM1. BMC Cancer.
24:6822024. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yu Y, Hao J, Wang L, Zheng X, Xie C, Liu
H, Wu J, Qiao S and Shi J: Astragaloside IV antagonizes the
malignant progression of breast cancer induced by macrophage M2
polarization through the TGF-β-regulated Akt/Foxo1 pathway. Pathol
Res Pract. 249:1547662023. View Article : Google Scholar
|
|
11
|
Dharmapal D, Jyothy A, Mohan A, Balagopal
PG, George NA, Sebastian P, Maliekal TT and Sengupta S: β-Tubulin
isotype, TUBB4B, regulates the maintenance of cancer stem cells.
Front Oncol. 11:7880242021. View Article : Google Scholar
|
|
12
|
Feng M, Wang K, Fu S, Wei H, Mu X, Li L
and Zhang S: Tubulin TUBB4B Is involved in spermatogonia
proliferation and cell cycle processes. Genes (Basel). 13:10822022.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang Y, Boza-Serrano A, Dunning CJR,
Clausen BH, Lambertsen KL and Deierborg T: Inflammation leads to
distinct populations of extracellular vesicles from microglia. J
Neuroinflammation. 15:1682018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McFadden JR, Tolete CDP, Huang Y,
Macnamara E, Sept D, Nesterova G, Gahl WA, Sackett DL and Malicdan
MCV: Clinical, genetic, and structural characterization of a novel
TUBB4B tubulinopathy. Mol Genet Metab Rep. 36:1009902023.PubMed/NCBI
|
|
15
|
Hu H, Zhang Y, Zhai H, Dong J, Zuo L, Guo
X and Wang C: P300 reduces TUBB4B expression to facilitate the
biological process of migration and invasion of non-small cell lung
cancer cells. Tissue Cell. 88:1023862024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang W, Zhang P, Pu Y, Chen Z, Su G, Deng
Y, Zhang Y, Ji Y, Huang Z, Zhou Q, et al: DNA
5-hydroxymethylcytosine landscape and transcriptional profile
highlight the TUBB4B-mediated Th17/Th1/Treg imbalance in Behçet's
uveitis. Invest Ophthalmol Vis Sci. 66:282025. View Article : Google Scholar
|
|
17
|
Sobierajska K, Ciszewski WM, Wawro ME,
Wieczorek-Szukała K, Boncela J, Papiewska-Pajak I, Niewiarowska J
and Kowalska MA: TUBB4B downregulation is critical for increasing
migration of metastatic colon cancer cells. Cells. 8:8102019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Filipovich E, Gorodkova E, Shcherbakova A,
Asaad W, Popov S, Melnichenko G, Mokrysheva N and Utkina M: The
role of cell cycle-related genes in the tumorigenesis of adrenal
and thyroid neuroendocrine tumors. Heliyon. 11:e414572024.
View Article : Google Scholar
|
|
19
|
Liu B, Wang J, Wang G, Jiang W, Li Z, Shi
Y, Zhang J, Pei Q, Huang G, Wang L, et al: Hepatocyte-derived
exosomes deliver H2AFJ to hepatic stellate cells and promote liver
fibrosis via the MAPK/STMN1 axis activation. Int Immunopharmacol.
115:096052023. View Article : Google Scholar
|
|
20
|
Wang C, Zhang H, Xu F, Niu Y, Wu Y, Wang
X, Peng Y, Sun J, Liang L and Xu P: Substituted 3-benzylcoumarins
as allosteric MEK1 inhibitors: Design, synthesis and biological
evaluation as antiviral agents. Molecules. 18:6057–6091. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
22
|
Elking DM: A non-periodic particle mesh
Ewald method for radially symmetric kernels in free space. Comput
Phys Commun. 312:1097392025. View Article : Google Scholar
|
|
23
|
Bussi G, Donadio D and Parrinello M:
Canonical sampling through velocity rescaling. J Chem Phys.
126:0141012007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hosseini AN and van der Spoel D: Martini
on the rocks: Can a coarse-grained force field model crystals? J
Phys Chem Lett. 15:1079–1088. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zocchi R, Compagnucci C, Bertini E and
Sferra A: Deciphering the tubulin language: Molecular determinants
and readout mechanisms of the tubulin code in neurons. Int J Mol
Sci. 24:27812023. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liu X, Chu W, Shang S, Ma L, Jiang C, Ding
Y, Wang J, Zhang S and Shao B: Preliminary study on the
anti-apoptotic mechanism of astragaloside IV on radiation-induced
brain cells. Int J Immunopathol Pharmacol. 34:20587384209545942020.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hu T, Fei Z and Wei N: Chemosensitive
effects of astragaloside IV in osteosarcoma cells via induction of
apoptosis and regulation of caspase-dependent Fas/FasL signaling.
Pharmacol Rep. 69:1159–1164. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu J, Wang D, Ren N, Zhang L and Wang T:
Metabolites of Astragalus membranaceus and their pro-apoptotic and
cytotoxic activities: Insights into targeted metabolic pathways.
Front Pharmacol. 16:16479582025. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wu M, Li K, Wu J, Zhang Q, Ma X, Dai W,
Gao H, Ding X, Wang W and Xiao W: Astragaloside IV: A multipotent
phytochemical for treating fibrotic diseases (Review). Int J Mol
Med. 57:502026.
|
|
30
|
Xu L and Li Y, He Z, Chen W and Li Y:
Astragaloside IV ameliorates experimental autoimmune myasthenia
gravis through multi-target regulation of
immune-microbiota-metabolism network and ferroptosis inhibition.
Pathol Res Pract. Feb 24–2026.Epub ahead of print. View Article : Google Scholar
|
|
31
|
Sanzhaeva U, Wonsettler NR, Rhodes SB and
Ramamurthy V: TUBB4B is essential for the expansion of
differentiating spermatogonia. Sci Rep. 14:208892024. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fang Z, Meng Q, Xu J, Wang W, Zhang B, Liu
J, Liang C, Hua J, Zhao Y, Yu X and Shi S: Signaling pathways in
cancer-associated fibroblasts: Recent advances and future
perspectives. Cancer Commun (Lond). 43:3–41. 2023. View Article : Google Scholar :
|
|
33
|
Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y and
Hu LL: ERK/MAPK signalling pathway and tumorigenesis. Exp Ther Med.
19:1997–2007. 2020.PubMed/NCBI
|
|
34
|
Zhang X, Ji J, Yang Y, Zhang J and Shen L:
Stathmin1 increases radioresistance by enhancing autophagy in
non-small-cell lung cancer cells. Onco Targets Ther. 9:2565–2574.
2016.PubMed/NCBI
|
|
35
|
Wang S, Su T, Tong H, Zhou D, Ma F, Ding
J, Hao Y, Shi W and Quan Z: Circβ-catenin promotes tumor growth and
Warburg effect of gallbladder cancer by regulating STMN1
expression. Cell Death Discov. 7:2332021. View Article : Google Scholar
|
|
36
|
Li J, Kong F, Wu K, Song K, He J and Sun
W: miR-193b directly targets STMN1 and uPA genes and suppresses
tumor growth and metastasis in pancreatic cancer. Mol Med Rep.
10:2613–2620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zeng L, Lyu X, Yuan J, Chen Y, Wen H,
Zhang L, Shi J, Liu B, Li W and Yang S: STMN1 promotes tumor
metastasis in non-small cell lung cancer through
microtubule-dependent and nonmicrotubule-dependent pathways. Int J
Biol Sci. 20:1509–1527. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li M and Zhou Q: Prognostic value of STMN1
expression in non-small cell lung cancer: A Meta-analysis. Zhongguo
Fei Ai Za Zhi. 27:826–830. 2024.In Chinese.
|
|
39
|
Zhang Y, Wei S, Zhang Q, Zhang Y and Sun
C: Paris saponin VII inhibits triple-negative breast cancer by
targeting the MEK/ERK/STMN1 signaling axis. Phytomedicine.
130:1557462024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Lovrić J, Dammeier S, Kieser A, Mischak H
and Kolch W: Activated raf induces the hyperphosphorylation of
stathmin and the reorganization of the microtubule network. J Biol
Chem. 273:22848–22855. 1998. View Article : Google Scholar
|
|
41
|
Ye Y, Liu L, Feng Z, Liu Y, Miao J, Wei X,
Li H, Yang J, Cao X and Zhao J: The ERK-cPLA2-ACSL4 axis mediating
M2 macrophages ferroptosis impedes mucosal healing in ulcerative
colitis. Free Radic Biol Med. 214:219–235. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang X, Li J, Jiang C, Zhang C, Yuan L,
Zhang T, Liu Y, Ma S, Kang P, Li D, et al: Splicing factor FUS
facilitates the progression of PIT1-lineage PitNETs by upregulating
MDM2. Theranostics. 16:3032–3049. 2026. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mitsutani M, Matsushita M, Yokoyama M,
Morita A, Hano H, Fujikawa T, Tagami T and Moriyama K: Growth
hormone directly stimulates GATA2 expression. Growth Horm IGF Res.
74:1015722024. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhou W, Zheng S, Ye L, Su T, Xie J, Jiang
L, Jiang Y, Zhong X, Wu L, Zhou W and Wang W: The USP8 mutational
status in combination with postsurgical cortisol levels for
predicting recurrence of cushing disease. J Clin Endocrinol Metab.
111:e156–e165. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kaparounaki C, Ilie MD, De Alcubierre D,
Anagnostis P, Haidich AB, Isidori AM, Dekkers OM, Goulis DG and
Raverot G: Medical treatment in acromegaly: A network
meta-analysis. Eur J Endocrinol. 193:S83–S94. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
He D, Wang Q, Sheng Z and Li G:
Preoperative medical therapy for acromegaly: Current knowledge and
clinical significance. Front Endocrinol (Lausanne). 16:16360472026.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kong P and Tang X, Liu F and Tang X:
Astragaloside IV regulates circ_0001615 and miR-873-5p/LASP1 axis
to suppress colorectal cancer cell progression. Chem Biol Drug Des.
103:e144232024. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Qiu T, Li D, Liu Y, Ren H, Yang X and Luo
W: Astragaloside IV inhibits the proliferation of human uterine
leiomyomas by targeting IDO1. Cancers (Basel). 14:44242022.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang X, Zhang F, Li Y, Fan N, Zhao K,
Zhang A, Kang J, Lin Y, Xue X and Jiang X: Blockade of PI3K/AKT
signaling pathway by astragaloside IV attenuates ulcerative colitis
via improving the intestinal epithelial barrier. J Transl Med.
22:4062024. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Li M, Niu Y, Tian L, Zhang T, Zhou S, Wang
L, Sun J, Wumiti T, Chen Z, Zhou Q, et al: Astragaloside IV
alleviates macrophage senescence and d-galactose-induced bone loss
in mice through STING/NF-κB pathway. Int Immunopharmacol.
129:1115882024. View Article : Google Scholar
|
|
51
|
Li L, Wang Q, He Y, Sun L, Yang Y and Pang
X: Astragaloside IV suppresses migration and invasion of
TGF-β1-induced human hepatoma HuH-7 cells by regulating
Nrf2/HO-1 and TGF-β1/Smad3 pathways. Naunyn
Schmiedebergs Arch Pharmacol. 395:397–405. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yu Z, Gao M, Wu X, Li J, Liu B, Wang R,
Tan J, Yu X and Geng L: Potential mechanisms and effects of
AFB1-induced asthma: A comprehensive analysis based on network
toxicology and molecular docking. PLoS One. 21:e03411722026.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Zou F, Du Q, Zhang Y, Zuo L and Sun Z:
Pseudo-allergic reactions induced by Chinese medicine injections: A
review. Chin Med. 18:1492023. View Article : Google Scholar : PubMed/NCBI
|
